Of interest, diabetes reportedly protects against the development of prostate cancer [8], [9], since it is testosterone-dependent and testosterone deficiency is common among men with diabetes secondary to low levels of sex hormone-binding globulin (SHBG) and partially because of insulin resistance [83]–[85]. This evidence concerns the gene SHBG and prostate cancer.